Zobrazeno 1 - 9
of 9
pro vyhledávání: '"QuynhChau D. Doan"'
Publikováno v:
Clinical Lymphoma and Myeloma. 8:140-145
The aim of this retrospective chart review of patients with multiple myeloma (MM) was to describe patterns of retreatment with bortezomib-based therapy and responses to retreatment in a community-based setting.Data were retrospectively extracted from
Autor:
QuynhChau D. Doan, Krista Yokoyama, Billy W. Woodward, John M. Jackimiec, Craig Clanton, Hoa T. Pham, Paul J. Godley
Publikováno v:
Journal of Managed Care Pharmacy. 8:23-30
OBJECTIVE: To evaluate the effect of physician profiles and academic detailing on cost and utilization of selective serotonin reuptake inhibitors (SSRIs) in a managed care population. DESIGN: A retrospective review of 153,072 SSRI pharmacy prescripti
Autor:
Alexandra San Roman, Quynhchau D. Doan, Urvi Desai, Woodie M. Zachry, Sapna Rao, Alice Kate G. Cummings, Noam Y. Kirson, Ryan M. Andrews, Jasmina I. Ivanova, Howard G. Birnbaum
Publikováno v:
Alzheimer's & Dementia. 8
Publikováno v:
Epilepsia. 50(3)
Summary Purpose: Although antiepileptic drugs (AEDs) with multisource generic alternatives are becoming more prevalent, no case-control studies have been published examining multisource medication use and epilepsy-related outcomes. This study evaluat
Publikováno v:
Journal of Clinical Lipidology. 2:228-229
Publikováno v:
American Journal of Hypertension. 15:A59-A60
Publikováno v:
Journal of Clinical Lipidology. 3:232
Publikováno v:
Blood. 108:3531-3531
BACKGROUND: The efficacy and safety of single agent bortezomib (btz) in relapsed MM is well established. In that setting, typically 8 cycles of therapy (6 months) are given and treatment stops. However, no therapy is curative and upon relapse, patien
Autor:
Vittorio Maio, Amishi B. Shah, Zeba M. Khan, QuynhChau D. Doan, Jennifer H. Lofland, Sujit S. Sansgiry, Jennifer Sung, Krista Yokoyama, Amy L. Phillips, Sandeep Duttagupta
Publikováno v:
American Journal of Pharmaceutical Education. 67:105
Objective. The purpose of this study was to describe the organizational structures and educational components of the pharmacoeconomics and outcomes research (PE/OR) fellowship programs in the United States. Methods. A survey questionnaire was adminis